[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100496559":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":28,"centralContacts":33,"locations":42,"responsibleParty":59,"collaborators":61,"id":79,"slug":80,"hasResults":81,"nctId":82,"briefTitle":83,"officialTitle":83,"acronym":10,"eligibilityCriteria":84,"healthyVolunteers":85,"sex":86,"minAge":87,"maxAge":88,"enrollmentInfo":89,"targetDuration":10,"studyType":92,"phases":10,"briefSummary":93,"conditions":94,"keywords":99,"overallStatus":44,"whyStopped":10,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":107,"completionDateStruct":109,"leadSponsor":111,"locationsCount":112},{"fullName":5,"class":6},"First Affiliated Hospital Xi'an Jiaotong University","OTHER",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Mild COVID-19 group",null,"Confirmed diagnosis of mild Covid-19 (WHO criteria)",[13],"Device: Simultaneous cortico-spinal magnetic resonance imaging, Serum",{"label":15,"type":10,"description":16,"interventionNames":17},"Moderate COVID-19 group","Confirmed diagnosis of moderate Covid-19 (WHO criteria)",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Uninfected Healthy controls","Healthy people who have not had COVID-19",[13],[23],{"type":24,"name":25,"description":26,"armGroupLabels":27,"otherNames":10},"DEVICE","Simultaneous cortico-spinal magnetic resonance imaging, Serum","Simultaneous cortico-spinal magnetic resonance imaging data were collected in a strong magnetic field and collected the serum of participants.",[9,15,19],[29],{"name":30,"affiliation":31,"role":32},"Ming Zhang, PhD","First Affiliated Hospital of Xian Jiaotong University","PRINCIPAL_INVESTIGATOR",[34,38],{"name":30,"role":35,"phone":36,"phoneExt":10,"email":37},"CONTACT","0086-18991232265","zmmri@163.com",{"name":39,"role":35,"phone":40,"phoneExt":10,"email":41},"Xuan Niu, PhD","0086-13289275082","niuxuan911@163.com",[43],{"facility":31,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"RECRUITING","Xi'an","Shaanxi","710061","China","CN",{"type":51,"coordinates":52},"Point",[53,54],108.92861,34.25833,{"lat":54,"lon":53},[57,58],{"name":30,"role":35,"phone":36,"phoneExt":10,"email":37},{"name":39,"role":35,"phone":40,"phoneExt":10,"email":41},{"type":60,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[62,65,67,69,71,73,75,77],{"name":63,"class":64},"Nuclear 215 Hospital of Shaanxi Province","UNKNOWN",{"name":66,"class":64},"Yanan Traditional Chinese Medicine Hospital",{"name":68,"class":6},"Shangluo Central Hospital",{"name":70,"class":64},"Xian QinHuang Hospital",{"name":72,"class":6},"Yulin No.2 Hospital",{"name":74,"class":6},"Hanzhong Central Hospital",{"name":76,"class":6},"Ankang Central Hospital",{"name":78,"class":64},"Baoji High-tech Hospital","100496559","cohort-follow-up-of-epidemic-and-neuroimaging-for-patients-during-the-1st-wave-of-the-covid-19-in-china-100496559",false,"NCT05745805","Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China","Inclusion Criteria:\n\nConfirmed diagnosis of mild Covid-19 (WHO criteria)\u002FConfirmed diagnosis of moderate Covid-19 (WHO criteria)\u002FHealthy people who have not had COVID-19\n\nExclusion Criteria:\n\nHistory of central nervous system diseases, such as mental disorder, degenerative diseases of central nervous system, tumors, trauma, etc. Participants with indication for MRI studies",true,"ALL","18 Years","65 Years",{"count":90,"type":91},600,"ESTIMATED","OBSERVATIONAL","Our main objective is to analyze the development of physical impact, mental health and blood profile over follow-up time during the 1st wave of the COVID-19. Besides, we aim to establish a database of post-COVID-19 based on simultaneous cortico-spinal magnetic resonance imaging data to identify high-risk patients with long COVID and prevent the neurological symptoms evolution, optimize the tactics of management in China.",[95,96,97,98],"COVID-19","Post-COVID-19 Syndrome","Acute COVID-19","Post-Acute COVID-19",[95,96,100,101,102],"Neuroimaging","Epidemic","Simultaneous Cortico-Spinal Magnetic Resonance Imaging","2023-02-24",{"date":105,"type":106},"2023-02-27","ACTUAL",{"date":108,"type":106},"2023-01-12",{"date":110,"type":91},"2026-09-12",{"name":5,"class":6},1]